Literature DB >> 14506739

A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.

Harriet C Hafkamp1, Ernst J M Speel, Annick Haesevoets, Fredrik J Bot, Winand N M Dinjens, Frans C S Ramaekers, Anton H N Hopman, Johannes J Manni.   

Abstract

Besides well-known risk factors such as tobacco use and alcohol consumption, oncogenic human papillomavirus (HPV) infection also has recently been suggested to promote head and neck tumorigenesis. HPV is known to cause cancer by inactivation of cell cycle regulators p53 and pRb via expression of viral oncoproteins E6 and E7. This indicates that p53 mutations are not a prerequisite in HPV-induced tumor development. However, discrepancy exists with respect to the frequency of head and neck squamous cell carcinomas (HNSCC) harboring DNA of oncogenic HPV and the fraction of these tumors showing p53 mutations. In our study, we examined the frequency of HNSCC demonstrating HPV 16/18 integration as identified by fluorescence in situ hybridization (FISH) and investigated their p53 (mutation) status by immunohistochemistry and single-strand conformation polymorphism (SSCP) analysis of exons 5-8. Paraffin-embedded, archival biopsy material from 27 premalignant mucosal lesions and 47 cases of HNSCC were analyzed. Ten of the 47 (21%) HNSCC unequivocally exhibited HPV 16 integration, including 8 of 12 (67%) tonsillar carcinomas. This is supported by the immunohistochemical detection of p16(INK4A) overexpression in all 10 HPV-positive tumors. Although FISH is considered to be less sensitive than PCR-based methods for HPV detection, our data clearly demonstrate clonal association of HPV with these tumors, as illustrated by the presence of integrated HPV 16 in both the primary tumor and their metastases in 2 patients. In contrast, HPV 16/18 DNA could not be detected in the premalignant lesions. In 30 of 47 (64%), HNSCC accumulation of p53 was observed, including 8 of the 10 HPV-positive carcinomas. However, in none of the latter cases could mutations in exons 5-8 be identified, except for a polymorphism in codon 213 of exon 6 in one patient. Evaluation of clinical data revealed a significant inverse relation between tobacco use with or without alcohol consumption, and HPV positivity of the tumors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506739     DOI: 10.1002/ijc.11389

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  80 in total

1.  UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.

Authors:  Alice L Tang; Samantha J Hauff; John H Owen; Martin P Graham; Michael J Czerwinski; Jung Je Park; Heather Walline; Silvana Papagerakis; Jay Stoerker; Jonathan B McHugh; Douglas B Chepeha; Carol R Bradford; Thomas E Carey; Mark E Prince
Journal:  Head Neck       Date:  2011-12-13       Impact factor: 3.147

2.  mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.

Authors:  Alfredo A Molinolo; Christina Marsh; Mohamed El Dinali; Nitin Gangane; Kaitlin Jennison; Stephen Hewitt; Vyomesh Patel; Tanguy Y Seiwert; J Silvio Gutkind
Journal:  Clin Cancer Res       Date:  2012-03-12       Impact factor: 12.531

3.  Analysis of P53 mutation and invasion front grading in oral squamous cell carcinomas.

Authors:  Sanbao Tang; Dongxuan Xu; Bin Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

4.  HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS.

Authors:  Katerina Strati; Paul F Lambert
Journal:  Expert Opin Med Diagn       Date:  2008-01-01

Review 5.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

Review 6.  Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.

Authors:  Maura L Gillison
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

7.  Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.

Authors:  Solomon Jo; Agnes Juhasz; Keqiang Zhang; Christopher Ruel; Sofia Loera; Sharon P Wilczynski; Yun Yen; Xiyong Liu; Joshua Ellenhorn; Dean Lim; Benjamin Paz; George Somlo; Nayana Vora; Stephen Shibata
Journal:  Anticancer Res       Date:  2009-05       Impact factor: 2.480

8.  Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer.

Authors:  Elaine M Smith; Linda M Rubenstein; Henry Hoffman; Thomas H Haugen; Lubomir P Turek
Journal:  Infect Agent Cancer       Date:  2010-02-11       Impact factor: 2.965

9.  Low prevalence of human papillomavirus in oral cavity carcinomas.

Authors:  Jerry Machado; Patricia P Reis; Tong Zhang; Colleen Simpson; Wei Xu; Bayardo Perez-Ordonez; David P Goldstein; Dale H Brown; Ralph W Gilbert; Patrick J Gullane; Jonathan C Irish; Suzanne Kamel-Reid
Journal:  Head Neck Oncol       Date:  2010-03-12

10.  MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.

Authors:  George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Demosthenis Skarlos
Journal:  J Oncol       Date:  2009-12-29       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.